We have located links that may give you full text access.
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS INCREASE SOLID GASTRIC RESIDUE RATES ON UPPER ENDOSCOPY ESPECIALLY IN COMPLICATED DIABETIC PATIENTS: A CASE CONTROL STUDY.
American Journal of Gastroenterology 2024 March 28
OBJECTIVE: Glucagon-like peptide-1 receptor agonists (GLP-1RA) prescribed for weight loss and type 2 diabetes mellitus (T2DM) can delay gastric emptying but risk factors and impact on procedure outcomes remain unclear.
METHODS: We compared frequency of gastric residue on upper endoscopy in patients on a GLP-1RA and propensity-score matched controls in this retrospective case-control study of consecutive patients undergoing endoscopic procedures over a 3.5 year period. GLP-1RAs were not held before endoscopy. Gastric residue presence was assessed by reviewing endoscopy reports and images. Predictors and consequences of gastric residue with GLP-1RA were determined.
RESULTS: In 306 GLP-1RA users compared to matched controls, rates of gastric residue were significantly higher with GLP-1RA use (14% vs 4%, p<0.01), especially in T2DM patients (14% vs 4%, p < 0.01), with insulin dependence (17% vs. 5%, p<0.01) and T2DM complications (15% vs. 2%, p < 0.01). Lower gastric residue rates were noted after prolonged fasting and clear liquids for concurrent colonoscopy (2% vs 11%, p<0.01), and in patients with afternoon procedures (4% vs 11%, p<0.01). While 22% with gastric residue required intubation and 25% had early procedure termination, no procedural complications or aspiration were recorded.
CONCLUSIONS: GLP-1RA use is associated with increased gastric residue on upper endoscopy, particularly in T2DM patients, surpassing the impact of opiates alone. Risk is highest in the presence of T2DM complications, while prolonged fasting and a clear-liquid diet are protective. This increased risk of gastric residue does not appear to translate to an increased risk of procedural complications.
METHODS: We compared frequency of gastric residue on upper endoscopy in patients on a GLP-1RA and propensity-score matched controls in this retrospective case-control study of consecutive patients undergoing endoscopic procedures over a 3.5 year period. GLP-1RAs were not held before endoscopy. Gastric residue presence was assessed by reviewing endoscopy reports and images. Predictors and consequences of gastric residue with GLP-1RA were determined.
RESULTS: In 306 GLP-1RA users compared to matched controls, rates of gastric residue were significantly higher with GLP-1RA use (14% vs 4%, p<0.01), especially in T2DM patients (14% vs 4%, p < 0.01), with insulin dependence (17% vs. 5%, p<0.01) and T2DM complications (15% vs. 2%, p < 0.01). Lower gastric residue rates were noted after prolonged fasting and clear liquids for concurrent colonoscopy (2% vs 11%, p<0.01), and in patients with afternoon procedures (4% vs 11%, p<0.01). While 22% with gastric residue required intubation and 25% had early procedure termination, no procedural complications or aspiration were recorded.
CONCLUSIONS: GLP-1RA use is associated with increased gastric residue on upper endoscopy, particularly in T2DM patients, surpassing the impact of opiates alone. Risk is highest in the presence of T2DM complications, while prolonged fasting and a clear-liquid diet are protective. This increased risk of gastric residue does not appear to translate to an increased risk of procedural complications.
Full text links
Related Resources
Trending Papers
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app